Search
forResearch 10 of 1000+
- PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
- Genome-wide gene expression dataset used to identify potential therapeutic targets in androgenetic alopecia
- Therapeutic targeting of ocular diseases with emphasis on PI3K/Akt, and OPRL pathways by Hedera helix L. saponins: a new approach for the treatment of Pseudomonas aeruginosa-induced bacterial keratitis
- Understanding the Molecular Landscape of Alopecia Areata: Key Genes, Regulatory Networks, and Therapeutic Targets
- Potential Therapeutic Targets for Androgenetic Alopecia (AGA) in Obese Individuals as Revealed by a Gut Microbiome Analysis: A Mendelian Randomization Study
- Therapeutic Strategies to Target the Androgen Receptor
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Targeting of Smoothened for therapeutic gain
- Targeting Ferroptosis in Sepsis: Therapeutic Potential and Mechanisms of Natural Products and Traditional Chinese Medicine
- Innovative Therapeutic Strategies in TYK2-Targeted Treatments: From Cancer to Autoimmune Disorders
Community 7 of 15
- IGFBP‐rP1 is a potential therapeutic target in androgenic alopecia
- Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
- mallia therapeutics 8T3 scd83 molecule for ffa/lpp mainly and aga
- The Chinese version of Stemson Therapeutics (Hair Multiplication) is here. It is called Yunce Medical.
- Eirion Therapeutics Announces Potential Breakthrough Treatment for Hair Loss Based on First-in-Man Clinical Trial Results
- Horrible news, Stemson Therapeutics has shut down
- Stemson Therapeutics Announces Technological Breakthrough in new Hair Growth